Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- Intervention Acceptability, Appropriateness, Feasibility
研究概览
简要总结
Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of Opioid Use Disorder (OUD)
- •Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication
- •Speak and understand English
排除标准
- •History of allergic reaction to buprenorphine
- •Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)
- •Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation
研究组 & 干预措施
Receiving Intervention
干预措施: Telemedicine Buprenorphine Treatment (Drug)
结局指标
主要结局
Intervention Acceptability, Appropriateness, Feasibility
时间窗: 48 weeks
To measure the participant intervention experience, the study team will utilize qualitative interview data with study participants. These data will be organized into the implementation science categories: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). The study team will determine whether each participant found the intervention to be feasible, acceptable, and/or appropriate. These findings will then be aggregated to better understand how participants experience the implementation of a telemedicine Opioid Use Disorder treatment organization, and will inform a future scaled-up implementation.
次要结局
- CDC's Health-Related Quality of Life - 4 (CDC HRQOL-4, also called the "Healthy Days Measures")(48 weeks)
- Brief Addiction Monitor(48 weeks)
- Visual Analogue Opioid Craving Scale(48 weeks)